Ahmed Hassan is the leader of the group of young Egyptian revolutionaries at the center of The Square.
Noujaim Films
Ahmed Hassan is the leader of the group of young Egyptian revolutionaries at the center of The Square.
Noujaim Films
The new documentary The Square — set in Cairo's Tahrir Square — is a gripping, visceral portrait of the 2011 Egyptian revolution and its tumultuous aftermath.
The film puts the audience directly in the middle of the protests, and follows the lives of several young revolutionaries over the two and half years since. It charts their journey from the early euphoria of victory to the depths of despair as those victories unravel amid violent clashes and profound political confrontations among the secular revolutionaries, the Muslim Brotherhood and the military.
The film's director, Egyptian-American filmmaker Jehane Noujaim, tells NPR's Robert Siegel that shooting the film was a real group effort.
"The entire team met in the square in 2011, and we all shot various parts of the film," she says. "We ended up with about 1,600 hours [of footage] and out of that made a hour-and-a-half film."
Interview Highlights
On being told at the Sundance Film Festival to go back and keep filming
People thought we were crazy, actually, because we did show it at [the] Sundance Film Festival. But as we were on the way to Sundance, our characters, all of them, were back in the streets fighting because President Morsi had pushed a constitution through and was claiming dictatorial powers. So it became a much more interesting story because it showed that the people that we followed and the people of Egypt were not going to rest. They were going to fight against fascism, whether the face of fascism was Mubarak or the army or the Muslim Brotherhood.
Director Jehane Noujaim grew up in Egypt and returned there to shoot the film, which was shown at the New York Film Festival this month.
Noujaim Films
Director Jehane Noujaim grew up in Egypt and returned there to shoot the film, which was shown at the New York Film Festival this month.
Noujaim Films
On telling this large story solely through the eyes of certain characters
The way that I make films is that I tell the story through the eyes of characters. And so if you follow the characters' journey, there are obviously things that you are leaving out. But the hope with a film like this is [to] make people feel like they've had a glimpse and really experienced revolution.
People don't get to experience what we've experienced or had a glimpse of the past couple of years. And once people are able to experience that, there are thousands of books out there that you can continue to read and gain an education on what's happening in Egypt. This isn't an interview film — we didn't go through an interview [with] every, you know, leader across Egypt on what was happening. We decided to really take it from the perspective of these young revolutionaries.
On how she felt about the revolutionaries she followed
I think you have to fall in love with your characters. ... You never know whether the film is ever going to get out there or whether anyone's going to see it. So you have to really like the people that you're following. You have to feel like you're learning something from them, that they're surprising you, that they're taking you to a place where you've never been, in the most enlightening kind of way.
So when I met Ahmed [Hassan], for example — he's the lead character in the film — I mean, he's one of the most charismatic, joyful, pure personalities that I've ever met. You talk to him, you just smile. You want to be with him. You want him to take you through this world.
On the revolutionaries' notion that 'We don't need leaders, we need a conscience'
It's something that we've talked about so many times. ... I've had these conversations with Ahmed, and what he says is, 'We need to create a society of consciousness, and out of that a good leader will emerge.' What Ahmed says in the film — and he's half joking — but he says, you know, 'I think one of the greatest achievements of this revolution is that you have these kids playing this game. That people demand the fall of the regime ... and some of them play Brotherhood and some of them play police and some of them play army.'
The Egypt that I grew up in, you could not have a conversation, a frank, political conversation with taxi drivers or different people in the street. People were worried about who is listening. Is this secret police? I shouldn't really say this because I could be carted away for this. And so the fact that people were standing in a square, talking about a future of a country that they wanted to create, that's a huge, huge shift.
And I think that that's incredibly important, whether these particular kids are able to stay in the street — they're not going to stay in the street. At a certain point it needs to go from the street to a constitution, [and then] to the ability to elect leaders that represent them. But until that constitution is written, and until there are the checks and balances that are supposed to exist — right now the street has been the ballot box.
And that leads to a very tumultuous — you know, you can't just, you can't lead by the streets forever, right? But that is the last two-and-a-half years that we've faced. And that's what we wanted to show.
The Marketplace Fairness Act is one of the most controversial bills currently making its way through the House. Those who support the bill claim it will help brick-and-mortar stores compete with online businesses whereas those who oppose it claim it will harm small businesses. Now one group has published a study finding that the bill would harm specific small businesses even more.
The Minority Media Telecommunications Council put out a new study finding that the Marketplace Fairness Act would harm small businesses, especially those owned by minorities and women. To be more specific, they say that the $1 million small business exemption won’t do enough to protect these businesses.
Do you think the current $1 million exemption is enough? Should the legislation take other metrics into account? Let us know in the comments.
To understand MMTC’s complaint, we have to first look at what the Marketplace Fairness Act’s exemptions. The bill, in its current form, would require any small business that makes over $1 million a year to collect sales tax on out of state online purchases. Opponents want to see that exemption raised to $10 million. When looking at the current state of small businesses, it certainly seems that a higher revenue threshold is needed.
A story published in September profiled a small business owner who makes about $3.5 million a year. Under the current proposed exemptions, he would have to collect state sales tax on all online sales made from outside of his state. Now, $3.5 million sounds like a lot, but he reported only $350 of operating income after all was said and done last year. The cost of having to comply with the Marketplace Fairness Act would put him, and countless other small businesses, in the red.
So, what does MMTC suggest lawmakers do about this? It says that “we need to think carefully about coming up with a more accurate definition of small businesses.” It suggests that lawmaker define small businesses by using the Small Business Administration’s definition. In other words, lawmakers should define small businesses on a case-by-case basis that’s determined by the industry it’s in and the number of employees it has alongside its revenue.
To be more specific, here’s what the SBA says constitutes a small retail business:
Most retail trade industries: $7 million
A few (such as grocery stores, department stores, motor vehicle dealers and electrical appliance dealers) have higher size standards, but none above $35.5 million (or 200 employees for New Car Dealers only).
Retail Trade NAICS codes and their size standards do not apply to Federal procurement of supplies. For Federal contracts set aside for small businesses a concern that supplies a product it did not manufacture (which is what a retailer would do) is a “nonmanufacturer.” To qualify as small for Federal government contracting, a nonmanufacturer must: 1) have 500 or fewer employees; 2) be primarily in the wholesale or retail trade and normally sell the type of the item9s) being supplied; 3) take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice; and 4) supply the end item of a United States small business manufacturer, processor or producer or obtain a waiver of such requirement pursuant to SBA’s regulations. This is called the “nonmanufacturer rule.” This rule does not apply to supply contracts of $25,000 or less that are processed under Simplified Acquisition Procedures.
There is a large variety of rules for other industries, but the Marketplace Fairness Act would predominantly affect the retail trade industry. Of course, the SBA’s definitions seemingly apply to brick-and-mortar small businesses as it makes no mention of online sales. Maybe the SBA should come up with new rules for online sellers, especially those who operate their own business through their own Web site alongside third-party seller sites like eBay and Etsy.
Speaking of eBay, the online seller has come out strongly against the Marketplace Fairness Act for many of the same reasons that the MMTC does. In a FAQ on its “Main Street” advocacy Web site, eBay says that it’s “opposed to the current definition of a small business in the legislation, which is exponentially less than any other relevant federal standard for defining a small business.”
eBay goes even further to say that the current $1 million exemption in the Marketplace Fairness Act only serves to protect the “casual online seller.” In other words, it would only protect your mom as she sells off a few family heirlooms a year on eBay. There would be no protection for the small business that also operates an eBay store to get their product out to more people.
In short, utilizing the Small Business Administration’s definition of a small business seems like the way to go. Defining a small business by the amount of money it makes is certainly metric to keep in mind, but it’s not the only thing that defines a small business. Keeping it focused strictly on revenue ignores the many costs that are associated with running a small business. Making these businesses keep track of sales tax rates for over 40 states would only add to those expenses, and would maybe even lead to those businesses having to cut back on other expenses, like employee retention programs.
Do you think the Marketplace Fairness Act should use the SBA’s definition of a small business? Or is using revenue as the sole metric fair? Let us know in the comments.
If you have trouble leaving a comment, review this help page. Still having problems? Let us know. If you find yourself moderated, take a moment to review our comment policy.
Monday marks Manhattan Beach Mayor David Lesser's monthly Walk 'N' Talk event starting at 8 a.m. at Peet's Coffee and Tea, 328 Manhattan Beach Blvd.
Anyone interested in talking with Lesser can join in a walk along The Strand. It should range from 60 to 90 minutes and will be rescheduled in the event of rain.
Former Mayors Nick Tell and Wayne Powell also held walks to connect with residents.
Reputation: Words written: Words per post: Joined: Last visit: Location: Website:
With each full moon there is a curse, some curses that can't be broken.
Owner:
Game Masters:
This topic is an Out Of Character part of the roleplay, ?Full Moon Rising?. Anything posted here will also show up there.
Topic Tags:
Forum for completely Out of Character (OOC) discussion, based around whatever is happening In Character (IC). Discuss plans, storylines, and events; Recruit for your roleplaying game, or find a GM for your playergroup.
First post: ? 1 post ? Page 1 of 1
This is the auto-generated OOC topic for the roleplay "Full Moon Rising"
You may edit this first post as you see fit.
Ville.Sunfall
Member for 0 years
First post: ? 1 post ? Page 1 of 1
Post a reply
RolePlayGateway is a site built by a couple roleplayers who wanted to give a little something back to the roleplay community. The site has no intention of earning any profit, and is paid for out of their own pockets.
If you appreciate what they do, feel free to donate your spare change to help feed them on the weekends. After selecting the amount you want to donate from the menu, you can continue by clicking on PayPal logo.
Our Sponsors
RolePlayGateway is proudly powered by obscene amounts of caffeine, duct tape, and support from people like you. It operates under a "don't like it, suggest an improvement" platform, and we gladly take suggestions for improvements or changes.
The custom-built "roleplay" system was designed and implemented by Eric Martindale as of July 2009. All attempts to replicate or otherwise emulate this system and its method of organizing roleplay are strictly prohibited without his express written and contractual permission; violators will be prosecuted to the fullest extent of the law.
? RolePlayGateway, LLC | with the support of LocalSense
I am currently working on a turn based style game-similar to the way words with friends works. I was planning on using a database service such as Parse or Stack mob. However I have recently been looking into Game center and Google's Game Services.
What are some of the benefits of using a database as a service such as parse or stack mob over using Game Center or Google Play's Game Services.
By: Angela Ayles on Thursday, August 1st, 2013 @ 2:33 pm?
Breast cancer is the most commonly diagnosed cancer among women in the United States?with one in every 8 women developing this cancer. Breast cancer typically develops as a small tumor (or lump) in the tissues throughout the breasts and then, if cancerous, spreads through the lymph nodes.
The best hope of surviving a breast cancer diagnosis is via early detection. That?s why routine self-exams of the breasts to identify any lumps, as well as annual check-ups and mammograms with your health care professional are important.
Here are 10 early warning signs to look out for during your self-breast exams at home?
1. Detection of a Lump
When performing a self breast exam, carefully apply pressures to the breasts and surrounding tissues with your fingers. Both benign (non cancerous) and malignant (cancerous) breast lumps sometimes form under the armpit, in the collarbone, near the site of the lymph nodes, and around the nipples, as rigid, hard, tender lumps that don?t move when you press against them. Any tenderness may be due to swollen tissues. If you detect a lump, call your doctor immediately.
Just a few weeks ago, Apple found itself on the wrong side of a decision when US District Judge Denise Cote ruled that Apple had, in fact, conspired with book publishers to raise the price of e-books across the industry.
Today, the DOJ announced a proposed remedy for Apple's alleged wrongdoing. The remedy aims to stop Apple's "illegal activities" and restore competition to the e-book marketplace.
As laid out by the DOJ, the proposed remedy not only requires Apple to put an end to its existing agency-model contracts with book publishers, but also precludes Apple from entering into "new e-book distribution contracts which would restrain Apple from competing on price."
The DOJ writes:
Under the department's proposed remedy, Apple will be prohibited from again serving as a conduit of information among the conspiring publishers or from retaliating against publishers for refusing to sell e-books on agency terms. Apple will also be prohibited from entering into agreements with suppliers of e-books, music, movies, television shows or other content that are likely to increase the prices at which Apple's competitor retailers may sell that content. To reset competition to the conditions that existed before the conspiracy, Apple must also for two years allow other e-book retailers like Amazon and Barnes & Noble to provide links from their e-book apps to their e-bookstores, allowing consumers who purchase and read e-books on their iPads and iPhones easily to compare Apple's prices with those of its competitors.
That certainly seems heavy handed.
The DOJ also recommends that Apple be appointed an external monitor by the court who will ensure that the company doesn't run afoul of any antitrust laws going forward. And as if that weren't enough, the monitor's salary and expenses will, according to the proposal, be paid for by Apple.
Think the DOJ is done?
Not quite.
The DOJ also recommends that Apple hire an internal antitrust compliance officer who will not only ensure that Apple complies with court imposed remedies, but will also be tasked with training and educating Apple's senior executives and employees about pertinent antitrust laws.
We all know stars undergo major transformations by a team of makeup artists to look gorgeous. But what do these stars look like without their “face” on? We’ve compiled a gallery of today’s major celebrities to see what they look like au naturel. Some actually look decent without being made up, while others are pretty ...
DUBAI (Reuters) - Two days before his inauguration as Iran's new president, Hassan Rouhani said on Friday that Israeli occupation of Palestinian land had inflicted a "wound" on the Muslim world, according to a segment of his remarks broadcast on Iran's state-run Press TV.
An earlier report by Iran's student news agency ISNA had quoted Rouhani as saying: "The Zionist regime is a wound that has sat on the body of the Muslim world for years and needs to be removed."
That version echoed the fiercely anti-Israeli language of outgoing President Mahmoud Ahmadinejad, but was swiftly repudiated by Iranian state media, which said unidentified news agencies had distorted Rouhani's remarks.
Press TV then broadcast an excerpt from an exchange between Rouhani and journalists at a rally to mark Iran's annual Al Qods Day in support of the Palestinians.
"After all, in our region there's been a wound for years on the body of the Muslim world under the shadow of the occupation of the holy land of Palestine and the beloved al-Qods (Jerusalem)," Rouhani said in the segment.
Israeli Prime Minister Benjamin Netanyahu seized on ISNA's version of Rouhani's comments, saying they showed the reputedly moderate Iranian cleric was as hostile to Israel as Ahmadinejad, whose denial of the Holocaust and description of Israel as a "cancerous tumor" prompted international condemnation.
The United States and its allies suspect Iran of seeking a nuclear weapons capability. Tehran says its nuclear program is purely for peaceful purposes, but Israel regards it as a threat to its existence and refuses to rule out military action.
With a more pragmatic president in Iran, Western countries may see a better chance for diplomacy to lead to a deal to curb Tehran's uranium enrichment program and avoid any conflict.
"The true face of Rouhani has been revealed sooner than expected. Even if they hurry to deny his words - this is what the man thinks and this is the Iranian regime's plan of action," Netanyahu said in a statement.
Rouhani's words "must awaken the world from the illusion in which part of it is placed since the Iranian elections", he declared, saying Iran still aimed "to acquire nuclear weapons in order to threaten Israel, the Middle East and world peace".
"A nation that threatens to destroy the state of Israel must not be allowed to have weapons of mass destruction," he said.
Ahmadinejad addressed Israel on Qods Day in his last speech as president. "You planted wind in our region and you will reap the storm. I swear to God that a ferocious storm is coming and it will uproot the Zionist entity," Iran's state news agency IRNA quoted him as saying.
(Reporting by Marcus George in Dubai and Ori Lewis in Jerusalem; writing by Alistair Lyon; editing by Jon Boyle)
[unable to retrieve full-text content]Lasrick writes "At the Dot Earth blog in the NY Times, 'Big companies have many, and sometimes conflicting, interests, as a spokesperson for Google tried to explain to the environmental blogger Brian Merchant this way: “[W]hile we disagree on climate change policy, we share an interest with Senator Inhofe in the employees and data center we have in Oklahoma.” Now the Web giant is facing fresh criticism, this time in an open letter from 17 scientists and policy researchers who were invited to Google’s Silicon Valley headquarters back in 2011 to explore ways to improve climate science communication....'"
New partnership strengthens global research efforts
Beijing, China/Rockville, MD, USAAugust 2, 2013 With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention (China CDC) and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.
While China has achieved significant reductions in TB illness and death over the past 30 years, TB remains a major public threat, with over one million new cases in China each year. A study published in the New England Journal of Medicine last year found that one in 10 cases of TB in China are resistant to the most commonly-used drugs. Based on the World Health Organization's estimates of global multidrug-resistant TB (MDR-TB), China has the highest annual number of cases of MDR-TB in the worlda quarter of the cases worldwide.
The new collaboration between China CDC and Aeras will accelerate research efforts for new vaccines by supporting studies that determine the incidence of TB infection, and will aim to strengthen the capacity within China to conduct future vaccine clinical trials.
"Innovation is the key to controlling and ultimately eliminating this disease," said Dr. Wang Yu, China CDC Director General. "And we have embraced innovation in our TB control efforts in China. We have adopted the latest technologies to diagnose TB. We have advanced innovative approaches to address TB and drug-resistant TB, and to promote the research that is necessary to urgently develop needed new tools to prevent, diagnose and treat it. We have made TB a high priority on our public health agenda, and will continue to seek out new and better ways to prevent and treat TB in communities across our country. But we know that this will not be enough. We will not defeat TB in our country or in the world without new, more effective vaccines. There is a coordinated, global effort underway to develop these urgently needed vaccines, and China must be a partner in this endeavor. With that goal in mind, we are excited to announce a new collaboration with Aeras to advance the research and development of new, more effective vaccines."
China CDC is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of services. Aeras is a nonprofit biotech based in Maryland, USA and Cape Town, South Africa, with the mission of advancing tuberculosis vaccines for the world. The meeting also marks the official opening by Aeras of an office in Beijing to facilitate and strengthen collaboration with Chinese researchers, partnerships that will be critical for developing tuberculosis vaccines for China and the world. Aeras supports half of the vaccine candidates currently in clinical trials, along with a portfolio of earlier stage candidates.
TB vaccine research and development requires dedicated investment and broad support to address scientific complexities and costs. No one organization or institution can do it alone, therefore global partnerships between individuals, research organizations, academic institutions, funders, policy-makers, and others are essential to advance TB vaccine science.
"Collaboration with Chinese researchers is crucial if we are going to defeat this global infectious disease killer," said Tom Evans, president & CEO of Aeras. "China has the technical expertise, resources and desire to develop effective vaccines against TB. Because of the high incidence of TB, the technical expertise, and a vaccine development infrastructure, China is perfectly poised to be at the forefront of global prevention efforts."
The global TB epidemic requires novel approaches, new tools and sufficient resources to mitigate what is now a more challenging and expensive disease to control than when the World Health Organization declared it a global emergency more than 20 years ago. The emergence of MDR-TB, now found in all countries surveyed worldwide, is confounding global efforts to halt the spread of TB and is putting an enormous economic burden on health systems globally. Alarmingly, new genetic research suggests that the bacterium could be poised to emerge stronger and more deadly than ever before, making it especially well-suited to spreading disease in a highly mobile and densely populated world.
"The ultimate game-changer in the battle to eliminate TB would be an improved vaccine that prevents children and adults from developing and transmitting disease," added Evans. The MOU was signed today during a meeting of global TB experts from the World Health Organization and other global leaders in TB research.
Tuberculosis is the world's second deadliest infectious disease, with 8.7 million new cases in 2011. Current guidelines require a minimum of six to nine months of treatment. TB is changing and evolving, making new vaccines more crucial for controlling the epidemic. Tuberculosis is the leading cause of death for people living with HIV/AIDS. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are hampering treatment and control efforts by making the disease more difficult to treat.
About Chinese Center for Disease Control and Prevention
Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of service. China CDC is committed to strengthening research on strategies and measures for disease control and prevention. China CDC organizes and implements control and prevention plans for different kinds of diseases; carries out public health management for food safety, occupational health, health related product safety, radiation health, environmental health, health care for women and children, among others; conducts applied scientific research; provides technical guidance, staff training and quality control for disease control and prevention and public health services throughout the country; and acts as a national working group for diseases prevention, emergency relief, and construction of public health information systems.
About Aeras
Aeras is a global nonprofit biotech advancing TB vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras is based in Rockville, Maryland, Cape Town, South Africa, and Beijing, China.
For more information, visit http://www.aeras.org
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Chinese CDC and Aeras sign agreement to collaborate on TB vaccine R&DPublic release date: 2-Aug-2013 [ | E-mail | Share ]
New partnership strengthens global research efforts
Beijing, China/Rockville, MD, USAAugust 2, 2013 With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention (China CDC) and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.
While China has achieved significant reductions in TB illness and death over the past 30 years, TB remains a major public threat, with over one million new cases in China each year. A study published in the New England Journal of Medicine last year found that one in 10 cases of TB in China are resistant to the most commonly-used drugs. Based on the World Health Organization's estimates of global multidrug-resistant TB (MDR-TB), China has the highest annual number of cases of MDR-TB in the worlda quarter of the cases worldwide.
The new collaboration between China CDC and Aeras will accelerate research efforts for new vaccines by supporting studies that determine the incidence of TB infection, and will aim to strengthen the capacity within China to conduct future vaccine clinical trials.
"Innovation is the key to controlling and ultimately eliminating this disease," said Dr. Wang Yu, China CDC Director General. "And we have embraced innovation in our TB control efforts in China. We have adopted the latest technologies to diagnose TB. We have advanced innovative approaches to address TB and drug-resistant TB, and to promote the research that is necessary to urgently develop needed new tools to prevent, diagnose and treat it. We have made TB a high priority on our public health agenda, and will continue to seek out new and better ways to prevent and treat TB in communities across our country. But we know that this will not be enough. We will not defeat TB in our country or in the world without new, more effective vaccines. There is a coordinated, global effort underway to develop these urgently needed vaccines, and China must be a partner in this endeavor. With that goal in mind, we are excited to announce a new collaboration with Aeras to advance the research and development of new, more effective vaccines."
China CDC is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of services. Aeras is a nonprofit biotech based in Maryland, USA and Cape Town, South Africa, with the mission of advancing tuberculosis vaccines for the world. The meeting also marks the official opening by Aeras of an office in Beijing to facilitate and strengthen collaboration with Chinese researchers, partnerships that will be critical for developing tuberculosis vaccines for China and the world. Aeras supports half of the vaccine candidates currently in clinical trials, along with a portfolio of earlier stage candidates.
TB vaccine research and development requires dedicated investment and broad support to address scientific complexities and costs. No one organization or institution can do it alone, therefore global partnerships between individuals, research organizations, academic institutions, funders, policy-makers, and others are essential to advance TB vaccine science.
"Collaboration with Chinese researchers is crucial if we are going to defeat this global infectious disease killer," said Tom Evans, president & CEO of Aeras. "China has the technical expertise, resources and desire to develop effective vaccines against TB. Because of the high incidence of TB, the technical expertise, and a vaccine development infrastructure, China is perfectly poised to be at the forefront of global prevention efforts."
The global TB epidemic requires novel approaches, new tools and sufficient resources to mitigate what is now a more challenging and expensive disease to control than when the World Health Organization declared it a global emergency more than 20 years ago. The emergence of MDR-TB, now found in all countries surveyed worldwide, is confounding global efforts to halt the spread of TB and is putting an enormous economic burden on health systems globally. Alarmingly, new genetic research suggests that the bacterium could be poised to emerge stronger and more deadly than ever before, making it especially well-suited to spreading disease in a highly mobile and densely populated world.
"The ultimate game-changer in the battle to eliminate TB would be an improved vaccine that prevents children and adults from developing and transmitting disease," added Evans. The MOU was signed today during a meeting of global TB experts from the World Health Organization and other global leaders in TB research.
Tuberculosis is the world's second deadliest infectious disease, with 8.7 million new cases in 2011. Current guidelines require a minimum of six to nine months of treatment. TB is changing and evolving, making new vaccines more crucial for controlling the epidemic. Tuberculosis is the leading cause of death for people living with HIV/AIDS. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are hampering treatment and control efforts by making the disease more difficult to treat.
About Chinese Center for Disease Control and Prevention
Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of service. China CDC is committed to strengthening research on strategies and measures for disease control and prevention. China CDC organizes and implements control and prevention plans for different kinds of diseases; carries out public health management for food safety, occupational health, health related product safety, radiation health, environmental health, health care for women and children, among others; conducts applied scientific research; provides technical guidance, staff training and quality control for disease control and prevention and public health services throughout the country; and acts as a national working group for diseases prevention, emergency relief, and construction of public health information systems.
About Aeras
Aeras is a global nonprofit biotech advancing TB vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras is based in Rockville, Maryland, Cape Town, South Africa, and Beijing, China.
For more information, visit http://www.aeras.org
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
More Below the Ad
Eternicom
We all know stars undergo major transformations by a team of makeup artists to look gorgeous. But what do these stars look like without their “face” on? We’ve compiled a gallery of today’s major celebrities to see what they look like au naturel. Some actually look decent without being made up, while others are pretty ...
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sFkzxn65WLod8tiKjiwP8ORfxIdYjEj7vCt0N_RLbhjTSSSDji8GRwLdzdoKZSz_ErQIev4DDUoiZdbNg9ONnwExUj_O-7CAHmpkWDIxc=s0-d){kind=small}
Public release date: 2-Aug-2013
Share ]